DKDiana H. Kearney

Diana H. Kearney

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Diana H. Kearney has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Biomarkers that differentiate false positive urinalyses from true urinary tract infection

    by Nader Shaikh, Judith M. Martin, Alejandro Hoberman, Megan Skae, Linette Milkovich, Christi McElheny, Robert W. Hickey, Lucine V. Gabriel, Diana H. Kearney, Massoud Majd, et al.

    Background The specificity of the leukocyte esterase test (87%) is suboptimal. The objective of this study was to identify more specific screening tests that could reduce the number of children who unnecessarily receive antimicrobials to treat a presumed urinary tract infection (UTI). Methods Prospective cross-sectional study to compare inflammatory proteins in blood and urine samples collected at the time of a presumptive diagnosis of UTI. We also evaluated serum RNA expression in a subset. Results We enrolled 200 children; of these, 89 were later demonstrated not to have a UTI based on the results of the urine culture obtained. Urinary proteins that best discriminated between children with UTI and no UTI were involved in T cell response proliferation (IL-9, IL-2), chemoattractants (CXCL12, CXCL1, CXCL8), the cytokine/interferon pathway (IL-13, IL-2, INFγ), or involved in innate immunity (NGAL). The predictive power (as measured by the area under the curve) of a combination of four urinary markers (IL-2, IL-9, IL-8, and NGAL) was 0.94. Genes in the pathways related to inflammation were also upregulated in serum of children with UTI. Conclusions Urinary proteins involved in the inflammatory response may be useful in identifying children with false positive results with current screening tests for UTI; this may reduce unnecessary treatment.


  • Open Access

    Factors That Influence Parental Decisions to Participate in Clinical Research

    by Alejandro Hoberman, Nader Shaikh, Sonika Bhatnagar, Mary Ann Haralam, Diana H. Kearney, D. Kathleen Colborn, Michelle L. Kienholz, Li Wang, Clareann H. Bunker, Ron Keren, et al.

    ImportanceA child's health, positive perceptions of the research team and consent process, and altruistic motives play significant roles in the decision-making process for parents who consent for their child to enroll in clinical research. This study identified that nonconsenting parents were better educated, had private insurance, showed lower levels of altruism, and less understanding of study design.ObjectiveTo determine the factors associated with parental consent for their child's participation in a randomized, placebo-controlled trial.DesignCross-sectional survey conducted from July 2008 to May 2011. The survey was an ancillary study to the Randomized Intervention for Children with VesicoUreteral Reflux Study.SettingSeven children's hospitals participating in a randomized trial evaluating management of children with vesicoureteral reflux.ParticipantsParents asked to provide consent for their child's participation in the randomized trial were invited to complete an anonymous online survey about factors influencing their decision. A total of 120 of the 271 (44%) invited completed the survey; 58 of 125 (46%) who had provided consent and 62 of 144 (43%) who had declined consent completed the survey.Main Outcomes and MeasuresA 60-question survey examining child, parent, and study characteristics; parental perception of the study; understanding of the design; external influences; and decision-making process.ResultsHaving graduated from college and private health insurance were associated with a lower likelihood of providing consent. Parents who perceived the trial as having a low degree of risk, resulting in greater benefit to their child and other children, causing little interference with standard care, or exhibiting potential for enhanced care, or who perceived the researcher as professional were significantly more likely to consent to participate. Higher levels of understanding of the randomization process, blinding, and right to withdraw were significantly positively associated with consent to participate.Conclusions and RelevanceParents who declined consent had a relatively higher socioeconomic status, had more anxiety about their decision, and found it harder to make their decision compared with consenting parents, who had higher levels of trust and altruism, perceived the potential for enhanced care, reflected better understanding of randomization, and exhibited low decisional uncertainty. Consideration of the factors included in the conceptual model should enhance the quality of the informed consent process and improve participation in pediatric clinical trials.


  • How Do Parents of Preverbal Children With Acute Otitis Media Determine How Much Ear Pain Their Child Is Having?

    by Nader Shaikh, Diana H. Kearney, D. Kathleen Colborn, Tracy Balentine, Wentao Feng, Yan Lin, Alejandro Hoberman